Precision BioSciences (DTIL)
Develops ARCUS-based in vivo gene-editing therapies.
$6.79
vs last close−0.40 (−5.56%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
estimated · in 40 days
EPS estimate
−$0.85
Revenue estimate
$1.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$3.20−$2.21−$2.13−$1.84$1.05−$0.75−$1.26Pending
Estimate−$2.09−$0.43−$0.09−$0.31−$0.21−$0.27−$0.80−$0.85
Surprise−53.1%−414.0%−2,266.7%−493.5%+600.0%−177.8%−56.7%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$638.0K$29.0K$18.0K$13.0K$34.2M$10.8M$0Pending
Estimate$10.0M$6.3M$5.4M$9.1M$9.1M$4.1M$740.0K$1.4M
Surprise−93.6%−99.5%−99.7%−99.9%+276.9%+167.6%−100.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.38 | — | — |
| Sep 2027 | −$0.37 | — | — |
| Jun 2027 | −$0.40 | — | — |
| Mar 2027 | −$0.39 | — | — |
| Dec 2026 | −$0.83 | — | — |
| Nov 2026 | −$0.85 | — | — |
| Aug 2026 | −$0.80 | −$1.26 | −56.7% |
| May 2026 | −$0.27 | −$0.75 | −177.8% |
| Mar 2026 | −$0.21 | $1.05 | +600.0% |
| Nov 2025 | −$0.31 | −$1.84 | −493.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Apr 2019 | |||
| Dec 2018 | |||
| Mar 2019 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.38 | — | — | $16.9M | — | — | — |
| Sep 2027 | −$0.37 | — | — | $2.5M | — | — | — |
| Jun 2027 | −$0.40 | — | — | $2.5M | — | — | — |
| Mar 2027 | −$0.39 | — | — | $2.5M | — | — | — |
| Dec 2026 | −$0.83 | — | — | $1.3M | — | — | — |
| Nov 2, 2026 | −$0.85 | — | — | $1.4M | — | — | — |
| Aug 6, 2026 | −$0.80 | −$1.26 | −56.7% | $740.0K | $0 | −100.0% | −0.7% |
| May 5, 2026 | −$0.27 | −$0.75 | −177.8% | $4.1M | $10.8M | +167.6% | −2.4% |
| Mar 12, 2026 | −$0.21 | $1.05 | +600.0% | $9.1M | $34.2M | +276.9% | +12.1% |
| Nov 3, 2025 | −$0.31 | −$1.84 | −493.5% | $9.1M | $13.0K | −99.9% | −9.8% |
| Aug 7, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 26, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 27, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 4, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 18, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 15, 2020 | |||||||
| Mar 10, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 14, 2019 | |||||||
| Apr 29, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Mar 28, 2019 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |